PAK4 confers the malignance of cervical cancers and contributes to the cisplatin-resistance in cervical cancer cells via PI3K/AKT pathway
Crossref DOI link: https://doi.org/10.1186/s13000-015-0404-z
Published Online: 2015-09-28
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shu, Xiang-Rong
Wu, Jing
Sun, He
Chi, Li-Qun
Wang, Jin-Huan